Search filters

List of works by Alicia Gutiérrez-Valencia

Cellular HIV reservoir replenishment is not affected by blip or intermittent viremia episodes during darunavir/ritonavir monotherapy.

scientific article published on January 2014

Darunavir minimum plasma concentration and ritonavir-boosted darunavir monotherapy outcome in HIV-infected patients

scientific article published on 16 January 2014

Darunavir/cobicistat showing similar effectiveness as darunavir/ritonavir monotherapy despite lower trough concentrations

scientific article published in February 2018

Deciphering the quality of SARS-CoV-2 specific T-cell response associated with disease severity, immune memory and heterologous response

scientific article published on 01 April 2022

Differences in HCV viral decline between low and standard-dose pegylated-interferon-alpha-2a with ribavirin in HIV/HCV genotype 3 patients

scientific article

Differential effects of viremia and microbial translocation on immune activation in HIV-infected patients throughout ritonavir-boosted darunavir monotherapy.

scientific article

Dimension of chronic hepatitis C virus in HIV-infected patients in the interferon-free era: an overview from south Spain

scientific article

Does Once-Daily Raltegravir Have Any Role in the Antiretroviral Treatment?

scientific article published on October 2015

Early initiation of antiretroviral therapy: debate over?

scientific article

Efficacy and safety of pegylated interferon plus ribavirin in HIV and hepatitis C virus-coinfected patients with advanced immunosuppression.

scientific article published in October 2009

Efficacy of Lysophosphatidylcholine in Combination with Antimicrobial Agents against Acinetobacter baumannii in Experimental Murine Peritoneal Sepsis and Pneumonia Models.

scientific article published on 09 May 2016

HIV-1 p24 and CD4+ T cell count during boosted protease-inhibitor monotherapy in HIV-infected patients.

scientific article published on 11 March 2016

Higher Activation in CD4(+) T Cells But Similar Viral Control Among HIV/Hepatitis C Virus-Coinfected Patients on a Simplification Monotherapy.

scientific article published on 28 September 2015

Immune activation throughout a boosted darunavir monotherapy simplification strategy.

scientific article published on 10 February 2014

Impact of the peginterferon-α 2a and ribavirin plasma levels on viral kinetics and sustained virological response in genotype 1 HCV/HIV-co-infected patients with the unfavourable non-CC IL28B genotypes

scientific article published on 17 July 2013

Intracellular and plasma pharmacokinetics of 400 mg of etravirine once daily versus 200 mg of etravirine twice daily in HIV-infected patients

scientific article published on 21 December 2011

Is immune recovery different depending on the use of integrase strand transfer inhibitor-, non-nucleoside reverse transcriptase- or boosted protease inhibitor-based regimens in antiretroviral-naive HIV-infected patients?

scientific article published on 01 January 2020

Low concordance and resistance mutation emergence in the HIV protease gene among circulating and cell-associated viruses at viral replication episodes during darunavir/ritonavir monotherapy.

scientific article published on 9 June 2014

Mesenchymal stromal cells in Human Immunodeficiency Virus-infected patients with discordant immune response: Early results of a phase I/II clinical trial

scientific article published on 02 December 2020

No difference in effectiveness of treatment simplification to boosted or unboosted atazanavir plus lamivudine in virologically suppressed in HIV-1-infected patients

scientific article published in PLoS ONE

Pharmacokinetic interactions between cobicistat-boosted elvitegravir and darunavir in HIV-infected patients.

scientific article published on 20 December 2016

Protease inhibitor monotherapy is effective in controlling human immunodeficiency virus 1 shedding in the male genital tract

scientific article published on 7 October 2015

Rapid virological response at week 4 predicts response to pegylated interferon plus ribavirin among HIV/HCV-coinfected patients.

scientific article published in January 2007

Role of pegylated interferon-alpha-2a and ribavirin concentrations in sustained viral response in HCV/HIV-coinfected patients.

scientific article published on 2 July 2008

Role of ritonavir in the drug interactions between telaprevir and ritonavir-boosted atazanavir.

scientific article published on 21 October 2013

Telaprevir and ribavirin interaction: higher ribavirin levels are not only due to renal dysfunction during triple therapy. ⬇️

scientific article published on 23 March 2015

The IL28B effect on hepatitis C virus kinetics among HIV patients after the first weeks of pegylated-interferon/ribavirin treatment varies according to hepatitis C virus-1 subtype.

scientific article published on July 2013

The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection.

scientific article published on 11 September 2007

Viral kinetics in semen with different antiretroviral families in treatment-naïve HIV-infected patients: a randomized trial.

scientific article published on 25 April 2017

Paulina is supported by:

About Paulina

Help